Role of Ultrasound-Based Therapies in Cardiovascular Diseases.

Amit Bansal, Bernard Bulwer, Ricarda von Krüchten, Jagkirat Singh, Rajan Rehan, Ata Doost

Abstract readReview

In one paragraph

Review in Structural heart : the journal of the Heart Team, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amit BansalBergen COVID-19 Research group and Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.

Bernard BulwerCardiovascular Imaging Core Laboratory, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston.

Ricarda von KrüchtenStanford University, School of Medicine, Stanford, United States.

Jagkirat SinghDepartment of Neurology, Creighton University, School of Medicine, Omaha.

Rajan RehanUniversity of Sydney Medical School, Sydney, Australia.

Ata DoostMacquarie University, Faculty of Medicine and Health Sciences and Macquarie University Hospital, Sydney, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality globally, placing an immense burden on health care costs worldwide. The emergence of therapeutic ultrasound-based therapies in the CVD management represents a promising innovative strategy beyond current established approaches. This paper explores three distinct modalities of ultrasound-based therapies-high-intensity focused ultrasound, extracorporeal shock wave therapy, and low-intensity pulsed ultrasound-each characterized by unique acoustic parameters and mechanisms of action tailored to specific therapeutic outcomes. High-intensity focused ultrasound was shown to be beneficial as an adjunct in the treatment of myocardial infarction and arrhythmias. It has also been investigated for the

Indexed as

Cardiovascular diseaseECSWTExtracorporeal cardiac shock wave therapyHIFUHigh-intensity focused ultrasoundLIULow-intensity ultrasoundTherapeutic ultrasound

Identifiers

PMID40124079

DOI10.1016/j.shj.2024.100349

PMCPMC11925036

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.